Loading…

Chemokines and allergic disease

Understanding the chemokine network has become one of the great challenges for researchers interested in inflammatory mechanisms and inflammation-based diseases. The complexity and diversity of the system provide not only a daunting task for its comprehension but also numerous opportunities for deve...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 1999-10, Vol.104 (4), p.723-742
Main Authors: Nickel, Renate, Beck, Lisa A., Stellato, Cristiana, Schleimer, Robert P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323
cites cdi_FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323
container_end_page 742
container_issue 4
container_start_page 723
container_title Journal of allergy and clinical immunology
container_volume 104
creator Nickel, Renate
Beck, Lisa A.
Stellato, Cristiana
Schleimer, Robert P.
description Understanding the chemokine network has become one of the great challenges for researchers interested in inflammatory mechanisms and inflammation-based diseases. The complexity and diversity of the system provide not only a daunting task for its comprehension but also numerous opportunities for development of new, targeted therapies. It is now certain that chemokines are involved as important mediators of allergic inflammation; the fine details and scope of their roles are now under investigation. Presumably, because of distinct pressures on the immune systems of people living in different geographic regions, genetic variation of ligands, receptors, and regulatory regions in the network have emerged. Establishing the roles of these polymorphisms in determining disease susceptibility or progression among individuals and in distinct ethnic groups will provide a basis for improved understanding and treatment of allergic diseases. (J Allergy Clin Immunol 1999;104:723-42.)
doi_str_mv 10.1016/S0091-6749(99)70281-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70830637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674999702812</els_id><sourcerecordid>70830637</sourcerecordid><originalsourceid>FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_gtqDiB5WJ8lmk5xEil9Q8KCeQzY7q9H9qEkr-O_tdot662kYeN53hoeQQwoXFGh2-QSgaZLJVJ9pfS6BKZqwLTKkoGWSKSa2yfAXGZC9GN9huXOld8mAgqBKUTEkx5M3rNsP32Ac26YY26rC8OrduPARbcR9slPaKuLBeo7Iy-3N8-Q-mT7ePUyup4kTDOaJQpsiQ-BCuJza3MnUcsFE7pgrUZa5yjVTmgOnTAEvCyvS1LJSobN5yRkfkdO-dxbazwXGual9dFhVtsF2EY0ExSHjciNIZSp0JrtG0YMutDEGLM0s-NqGb0PBdArNSqHp_BitzUqh6XJH6wOLvMbiX6p3tgRO1oCNzlZlsI3z8Y_TSmTQPXrVY7jU9uUxmOg8Ng4LH9DNTdH6DZ_8AHgPi7E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17459672</pqid></control><display><type>article</type><title>Chemokines and allergic disease</title><source>ScienceDirect Freedom Collection</source><creator>Nickel, Renate ; Beck, Lisa A. ; Stellato, Cristiana ; Schleimer, Robert P.</creator><creatorcontrib>Nickel, Renate ; Beck, Lisa A. ; Stellato, Cristiana ; Schleimer, Robert P.</creatorcontrib><description>Understanding the chemokine network has become one of the great challenges for researchers interested in inflammatory mechanisms and inflammation-based diseases. The complexity and diversity of the system provide not only a daunting task for its comprehension but also numerous opportunities for development of new, targeted therapies. It is now certain that chemokines are involved as important mediators of allergic inflammation; the fine details and scope of their roles are now under investigation. Presumably, because of distinct pressures on the immune systems of people living in different geographic regions, genetic variation of ligands, receptors, and regulatory regions in the network have emerged. Establishing the roles of these polymorphisms in determining disease susceptibility or progression among individuals and in distinct ethnic groups will provide a basis for improved understanding and treatment of allergic diseases. (J Allergy Clin Immunol 1999;104:723-42.)</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/S0091-6749(99)70281-2</identifier><identifier>PMID: 10518815</identifier><identifier>CODEN: JACIBY</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Allergic disease ; Allergic diseases ; angiogenesis ; Biological and medical sciences ; chemokine ; Chemokines - antagonists &amp; inhibitors ; Chemokines - classification ; Chemokines - genetics ; Chemokines - metabolism ; chemotaxis ; Chemotaxis, Leukocyte ; Chromosome Mapping ; Continental Population Groups ; cytokines ; Endothelium, Vascular ; eosinophil ; General aspects ; glucocorticoids ; hematopoieses ; Hematopoiesis ; Humans ; Hypersensitivity - epidemiology ; Hypersensitivity - immunology ; Immunopathology ; mediators ; Medical sciences ; Models, Immunological ; Neovascularization, Physiologic ; Receptors, Chemokine - antagonists &amp; inhibitors ; Receptors, Chemokine - classification ; Receptors, Chemokine - genetics ; Receptors, Chemokine - metabolism ; transendothelial migration</subject><ispartof>Journal of allergy and clinical immunology, 1999-10, Vol.104 (4), p.723-742</ispartof><rights>1999 Mosby, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323</citedby><cites>FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1985607$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10518815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nickel, Renate</creatorcontrib><creatorcontrib>Beck, Lisa A.</creatorcontrib><creatorcontrib>Stellato, Cristiana</creatorcontrib><creatorcontrib>Schleimer, Robert P.</creatorcontrib><title>Chemokines and allergic disease</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Understanding the chemokine network has become one of the great challenges for researchers interested in inflammatory mechanisms and inflammation-based diseases. The complexity and diversity of the system provide not only a daunting task for its comprehension but also numerous opportunities for development of new, targeted therapies. It is now certain that chemokines are involved as important mediators of allergic inflammation; the fine details and scope of their roles are now under investigation. Presumably, because of distinct pressures on the immune systems of people living in different geographic regions, genetic variation of ligands, receptors, and regulatory regions in the network have emerged. Establishing the roles of these polymorphisms in determining disease susceptibility or progression among individuals and in distinct ethnic groups will provide a basis for improved understanding and treatment of allergic diseases. (J Allergy Clin Immunol 1999;104:723-42.)</description><subject>Allergic disease</subject><subject>Allergic diseases</subject><subject>angiogenesis</subject><subject>Biological and medical sciences</subject><subject>chemokine</subject><subject>Chemokines - antagonists &amp; inhibitors</subject><subject>Chemokines - classification</subject><subject>Chemokines - genetics</subject><subject>Chemokines - metabolism</subject><subject>chemotaxis</subject><subject>Chemotaxis, Leukocyte</subject><subject>Chromosome Mapping</subject><subject>Continental Population Groups</subject><subject>cytokines</subject><subject>Endothelium, Vascular</subject><subject>eosinophil</subject><subject>General aspects</subject><subject>glucocorticoids</subject><subject>hematopoieses</subject><subject>Hematopoiesis</subject><subject>Humans</subject><subject>Hypersensitivity - epidemiology</subject><subject>Hypersensitivity - immunology</subject><subject>Immunopathology</subject><subject>mediators</subject><subject>Medical sciences</subject><subject>Models, Immunological</subject><subject>Neovascularization, Physiologic</subject><subject>Receptors, Chemokine - antagonists &amp; inhibitors</subject><subject>Receptors, Chemokine - classification</subject><subject>Receptors, Chemokine - genetics</subject><subject>Receptors, Chemokine - metabolism</subject><subject>transendothelial migration</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LAzEQhoMotlZ_gtqDiB5WJ8lmk5xEil9Q8KCeQzY7q9H9qEkr-O_tdot662kYeN53hoeQQwoXFGh2-QSgaZLJVJ9pfS6BKZqwLTKkoGWSKSa2yfAXGZC9GN9huXOld8mAgqBKUTEkx5M3rNsP32Ac26YY26rC8OrduPARbcR9slPaKuLBeo7Iy-3N8-Q-mT7ePUyup4kTDOaJQpsiQ-BCuJza3MnUcsFE7pgrUZa5yjVTmgOnTAEvCyvS1LJSobN5yRkfkdO-dxbazwXGual9dFhVtsF2EY0ExSHjciNIZSp0JrtG0YMutDEGLM0s-NqGb0PBdArNSqHp_BitzUqh6XJH6wOLvMbiX6p3tgRO1oCNzlZlsI3z8Y_TSmTQPXrVY7jU9uUxmOg8Ng4LH9DNTdH6DZ_8AHgPi7E</recordid><startdate>19991001</startdate><enddate>19991001</enddate><creator>Nickel, Renate</creator><creator>Beck, Lisa A.</creator><creator>Stellato, Cristiana</creator><creator>Schleimer, Robert P.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19991001</creationdate><title>Chemokines and allergic disease</title><author>Nickel, Renate ; Beck, Lisa A. ; Stellato, Cristiana ; Schleimer, Robert P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Allergic disease</topic><topic>Allergic diseases</topic><topic>angiogenesis</topic><topic>Biological and medical sciences</topic><topic>chemokine</topic><topic>Chemokines - antagonists &amp; inhibitors</topic><topic>Chemokines - classification</topic><topic>Chemokines - genetics</topic><topic>Chemokines - metabolism</topic><topic>chemotaxis</topic><topic>Chemotaxis, Leukocyte</topic><topic>Chromosome Mapping</topic><topic>Continental Population Groups</topic><topic>cytokines</topic><topic>Endothelium, Vascular</topic><topic>eosinophil</topic><topic>General aspects</topic><topic>glucocorticoids</topic><topic>hematopoieses</topic><topic>Hematopoiesis</topic><topic>Humans</topic><topic>Hypersensitivity - epidemiology</topic><topic>Hypersensitivity - immunology</topic><topic>Immunopathology</topic><topic>mediators</topic><topic>Medical sciences</topic><topic>Models, Immunological</topic><topic>Neovascularization, Physiologic</topic><topic>Receptors, Chemokine - antagonists &amp; inhibitors</topic><topic>Receptors, Chemokine - classification</topic><topic>Receptors, Chemokine - genetics</topic><topic>Receptors, Chemokine - metabolism</topic><topic>transendothelial migration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nickel, Renate</creatorcontrib><creatorcontrib>Beck, Lisa A.</creatorcontrib><creatorcontrib>Stellato, Cristiana</creatorcontrib><creatorcontrib>Schleimer, Robert P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nickel, Renate</au><au>Beck, Lisa A.</au><au>Stellato, Cristiana</au><au>Schleimer, Robert P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemokines and allergic disease</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>1999-10-01</date><risdate>1999</risdate><volume>104</volume><issue>4</issue><spage>723</spage><epage>742</epage><pages>723-742</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><coden>JACIBY</coden><abstract>Understanding the chemokine network has become one of the great challenges for researchers interested in inflammatory mechanisms and inflammation-based diseases. The complexity and diversity of the system provide not only a daunting task for its comprehension but also numerous opportunities for development of new, targeted therapies. It is now certain that chemokines are involved as important mediators of allergic inflammation; the fine details and scope of their roles are now under investigation. Presumably, because of distinct pressures on the immune systems of people living in different geographic regions, genetic variation of ligands, receptors, and regulatory regions in the network have emerged. Establishing the roles of these polymorphisms in determining disease susceptibility or progression among individuals and in distinct ethnic groups will provide a basis for improved understanding and treatment of allergic diseases. (J Allergy Clin Immunol 1999;104:723-42.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>10518815</pmid><doi>10.1016/S0091-6749(99)70281-2</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 1999-10, Vol.104 (4), p.723-742
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_70830637
source ScienceDirect Freedom Collection
subjects Allergic disease
Allergic diseases
angiogenesis
Biological and medical sciences
chemokine
Chemokines - antagonists & inhibitors
Chemokines - classification
Chemokines - genetics
Chemokines - metabolism
chemotaxis
Chemotaxis, Leukocyte
Chromosome Mapping
Continental Population Groups
cytokines
Endothelium, Vascular
eosinophil
General aspects
glucocorticoids
hematopoieses
Hematopoiesis
Humans
Hypersensitivity - epidemiology
Hypersensitivity - immunology
Immunopathology
mediators
Medical sciences
Models, Immunological
Neovascularization, Physiologic
Receptors, Chemokine - antagonists & inhibitors
Receptors, Chemokine - classification
Receptors, Chemokine - genetics
Receptors, Chemokine - metabolism
transendothelial migration
title Chemokines and allergic disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A26%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemokines%20and%20allergic%20disease&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Nickel,%20Renate&rft.date=1999-10-01&rft.volume=104&rft.issue=4&rft.spage=723&rft.epage=742&rft.pages=723-742&rft.issn=0091-6749&rft.eissn=1097-6825&rft.coden=JACIBY&rft_id=info:doi/10.1016/S0091-6749(99)70281-2&rft_dat=%3Cproquest_cross%3E70830637%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c520t-8ea4e2e0355cb1abc74a3525bc2cfe7fb8b928930312803fda544a2f8ecabf323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17459672&rft_id=info:pmid/10518815&rfr_iscdi=true